Abstract:Germline mutations in the folliculin (FLCN) tumor suppressor gene are linked to Birt-Hogg-Dubé (BHD) syndrome, a dominantly inherited genetic disease characterized by predisposition to fibrofolliculomas, lung cysts, and renal cancer. Most BHD-linked FLCN variants include large deletions and splice site aberrations predicted to cause loss of function. The mechanisms by which missense variants and short in-frame deletions in FLCN trigger disease are unknown. Here, we present an integrated computational and experimental study that reveals that the majority of such disease-causing FLCN variants cause loss of function due to proteasomal degradation of the encoded FLCN protein, rather than directly ablating FLCN function. Accordingly, several different single-site FLCN variants are present at strongly reduced levels in cells. In line with our finding that FLCN variants are protein quality control targets, several are also highly insoluble and fail to associate with the FLCN-binding partners FNIP1 and FNIP2. The lack of FLCN binding leads to rapid proteasomal degradation of FNIP1 and FNIP2. Half of the tested FLCN variants are mislocalized in cells, and one variant (ΔE510) forms perinuclear protein aggregates. A yeast-based stability screen revealed that the deubiquitylating enzyme Ubp15/USP7 and molecular chaperones regulate the turnover of the FLCN variants. Lowering the temperature led to a stabilization of two FLCN missense proteins, and for one (R362C), function was re-established at low temperature. In conclusion, we propose that most BHD-linked FLCN missense variants and small in-frame deletions operate by causing misfolding and degradation of the FLCN protein, and that stabilization and resulting restoration of function may hold therapeutic potential of certain disease-linked variants. Our computational saturation scan encompassing both missense variants and single site deletions in FLCN may allow classification of rare FLCN variants of uncertain clinical significance.

FLCN regulates transferrin receptor 1 transport and iron homeostasis

Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin

FLCN is a novel Rab11A-interacting protein that is involved in the Rab11A-mediated recycling transport.

Genetic Characterization Of The Drosophila Birt-Hogg-Dube Syndrome Gene

Folliculin, a Tumor Suppressor Associated with Birt-Hogg-Dubé (BHD) Syndrome, is a Novel Modifier of TDP-43 Cytoplasmic Translocation and Aggregation.

Folliculin Regulates Cell-Cell Adhesion, AMPK, and Mtorc1 in a Cell-Type-specific Manner in Lung-Derived Cells.

Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation

RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation

Ferroportin1 in Hepatocytes and Macrophages Mediates Systemic Iron Homeostasis

Ferroportin1 in Hepatocytes and Macrophages is Required for the Efficient Mobilization of Body Iron Stores in Mice

Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia.

YTHDF1-enhanced iron metabolism depends on TFRC m 6 A methylation.

Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis.

Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice

Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts

Detection of Folliculin Gene Mutations in Two Chinese Families with Birt-Hogg-Dube Syndrome.

Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia

Transferrin receptor 1-mediated iron uptake plays an essential role in hematopoiesis

Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis

FDX1 regulates cellular protein lipoylation through direct binding to LIAS.